Documents
208 documents
Sort by:
Subscribe to the latest documents
- Date
- Relevance
-
EMA: form for reporting a suspected adverse event of a veterinary medicinal product
-
Braille declaration
-
MEB Regulatory Science Day 2017
-
Classification overview legal status of supply NSAIDs
The MEB has determined a classification system for OTC anti-inflammatories (NSAIDs).
-
Assessment report DHA-rich algal oil, applicant NovoSana (Europe) B.V.
A report on the assessment of DHA-rich algal oil by the company NovoSana (Europe) B.V. for substantial equivalence to DHA-rich ...
-
Assessment report Chia seed, applicant DFInternational BV
A report on the assessment of chia seed by the company DFInternational B.V. for substantial equivalence to chia seed, which has ...
-
MEB 41: MEB policy concerning marketing authorisations without Dutch translations of the product information and/or mock-ups
The MEB is aware of the fact that medicinal products are not always marketed immediately after authorisation. Following the ...
-
Assessment report 2’-fucosyllactose, applicant Jennewein Biotechnologie GmbH
A report on the initial assessment of 2’-fucosyllactose by the company Jennewein Biotechnologie GmbH.
-
Heads of Medicines Agencies: Heads and IT directors meeting
-
HMA human stakeholders meeting